在英国国家产前筛查规划中实施无创产前检测:对孕妇选择的影响
该观察性研究纳入2018年4月30日至2020年9月25日英国威尔士所有单胎且初始筛查高风险(≤1:150)的孕妇,评估无创产前检测(NIPT)实施对孕妇选择的影响。结果显示84%选择NIPT作为后续检测,侵入性操作年均27例较实施前229例减少近九倍,唐氏综合征年活产率保持不变。
要点
- 高风险孕妇中84%选择NIPT作为后续检测,14%不再检测,2%选择侵入性操作。
- NIPT结果低风险占93%,检测失败占1%,高风险占6%。
- 侵入性操作年均27例,较实施前229例减少近九倍。
核心结论
- NIPT作为后续筛查在高风险孕妇中接受度高,并减少了侵入性操作的实施。
- NIPT在英国国家医疗服务体系产前筛查路径中的高接受度可为其他国家级筛查规划提供参考。
研究设计与样本
- 观察性研究,纳入2018年4月30日至2020年9月25日英国威尔士所有单胎且初始联合筛查或四联筛查结果为高风险(≤1:150)的孕妇。
- 评估路径包括NIPT的接受情况、非研究环境下NIPT的表现以及实施的侵入性操作。
主要发现
- 1273例初始筛查高风险孕妇中,1073例(84%)选择NIPT作为后续检测,174例(14%)未进一步检测,26例(2%)选择侵入性操作。
- NIPT结果中,1001例(93%)为低风险,11例(1%)检测失败,61例(6%)为高风险。
- 侵入性操作年均实施27例,而NIPT实施前为229例,减少近九倍。
- 唐氏综合征年活产率在实施期间保持不变。
临床怎么用
- 作者认为,NIPT作为后续筛查的高接受度及侵入性操作减少,可为其他国家级筛查规划提供参考。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the implementation of non-invasive prenatal testing (NIPT) on pregnant women's choices in a national NHS antenatal screening programme for Down's syndrome, Edwards' syndrome and Patau's syndrome. METHOD: An observational study of all pregnant women with a singleton pregnancy and higher chance (≤1:150) combined or quadruple screening result from 30 April 2018 to 25 September 2020 in Wales, UK. Pregnant women's journey through the pathway was determined including uptake of NIPT, performance of NIPT in a non-research setting and invasive procedures performed. RESULTS: Of the 1273 women with a higher chance initial screening, 1073 (84%) chose NIPT contingent test, 174 (14%) no further testing and 26 (2%) invasive procedure. There were 1001 (93%) low chance NIPT results; 11 (1%) failed results and 61 (6%) high chance results. Average annual incidence of 27 invasive procedures undertaken compared to 229 pre-NIPT implementation, a nearly ninefold reduction. Down's syndrome annual live birth rate remained unchanged across the implementation period. DISCUSSION: This study demonstrates that NIPT contingent screening was highly acceptable to women with a resulting reduction in invasive procedures performed. CONCLUSION: The high uptake of NIPT in NHS antenatal screening pathway conditions should inform planning for other national screening programmes.
引用
- Bowden B, de Souza S, Puchades A, et al. Implementation of non-invasive prenatal testing within a national UK antenatal screening programme: Impact on women's choices. Prenat Diagn. 2022. PMID: 35278232. doi:10.1002/pd.6131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。